Case Study: B2B2C Market Validation Strategy
Designing and executing a structured market validation program in regulated healthcare.
Executive Overview
Designed and executed a 24-day B2B2C validation program to test employer demand for ADHD care pathways in a regulated healthcare domain.
Entering a crowded market, I mapped competitors, discovered ICP personas, and identified a structural care-pathway gap. The work generated measurable engagement signals, secured ecosystem partnerships, and equipped founders with clear data on sales cycle dynamics and capital allocation trade-offs.
Impact
Transformed strategic uncertainty into validated insight, infrastructure, and optionality within 24 focused working days.
Enabled founders to confidently prioritise D2C revenue while preserving validated B2B infrastructure and future optionality.
Engagement vs Benchmark (2025)
I Achieved Engagement Rates Well Above B2B Benchmark References (2025)
The chart compares achieved open, click-through, and reply rates against benchmark references.
Highlights & Challenges
The Challenge
- • Crowded ADHD assessment market
- • Enterprise demand assumed but unvalidated
- • Regulated clinical risk environment
- • Undefined ICP and untested B2B messaging
- • Buyer assumption that ADHD was already covered
The Objective
Structured validation before scaling investment. Executed across approximately 24 focused working days.
1. Market Mapping
Mapped competitors by buyer type, risk posture, sales motion, and clinical positioning.
Structural gap identified:
Major employer providers covered diagnosis but did not provide supported medication pathways. This left a void in "Diagnosis without continuation of care."
Strategic reframe: Position the startup as completing the care pathway rather than duplicating assessment provision.
2. Persona Discovery
Validated three primary enterprise buyer groups: HR Leaders, DEI Leaders, and Benefits Leaders. Mapped pain points, compliance sensitivities, budget authority, and objection patterns.
Structural gap identified:
Major employer providers covered diagnosis but did not provide supported medication pathways. This left a void in "Diagnosis without continuation of care."
Strategic reframe: Position the startup as completing the care pathway rather than duplicating assessment provision.
This aligned directly with documented services: ADHD assessment, post-assessment care, medication titration, and shared care agreements.
3. Execution Infrastructure
Built a repeatable B2B operating model to create durable GTM infrastructure beyond the test period:
- • Persona-segmented outreach
- • Multi-channel contact strategy
- • HubSpot CRM workflows
- • Contact enrichment stack
- • Engagement analytics
- • Objection-handling library
Measured Signals (24 Working Days)
5,229
Structured outreach activities
29.9%
Email open rate
17.1%
Click-through rate
Ecosystem Impact
- • Affiliate partnership established with a respected neurodiversity advocate
- • Visibility partnership secured via high-trust ADHD resource platform
- • Resulting uplift in SEO rankings
- • Increase in inbound discovery driven by authority-based referral traffic
Strategic Outcome
The program validated buyer legitimacy, message resonance, and structural differentiation. Based on structured evidence, founders prioritised D2C due to faster revenue velocity, while the B2B2C pathway remains a viable, infrastructure-ready optionality.
This was a deliberate, data-informed strategic allocation decision.
Strategic Impact
Delivered evidence-based strategic clarity in a new regulated market. The program reframed the startup's market entry by:
- • Validating HR, DEI, and Benefits leaders as credible B2B buyers
- • Identifying structural differentiation rooted in care pathway completion
- • Quantifying enterprise sales cycle dynamics
- • Clarifying regulatory and operational trade-offs
- • Building reusable CRM, messaging, and outreach systems
Transferability
- Early-Stage Product Validation Building structural evidence before scaling investment.
- Regulated B2B2C Industries Navigating compliance and risk while identifying market gaps.
- Strategic Uncertainty Reduction Providing data-led clarity to inform capital allocation.